Chronic Kidney Disease News

A “critical gap” between recommended and commonly used nephrology practices, including kidney replacement therapy-directed education, exists, according to a published study.

Addressing disparities in standard of care in disease monitoring and perception of disease progression could improve treatment for adults with Fabry disease, according to published data.

Tumor necrosis factor inhibitor use was independently associated with a greater risk for progressive kidney function decline but not risk for all-cause mortality among patients with new-onset inflammatory bowel disease, according to data.

Adverse drug reactions make up a major cause of hospitalization in patients with chronic kidney disease where lower eGFR is a risk factor, according to published data.

Targeted educational and training programs may help address barriers that could limit cystatin C use in clinical practice for enhanced chronic kidney disease detection, according to published data.

BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.

Nephrology providers have limited knowledge and experience in offering conservative kidney management to patients who decide to forgo renal replacement therapy, recently published survey results show.

Co-chairs of a National Kidney Foundation-American Society of Nephrology task force on race in chronic kidney disease were named to the TIME list of the 100 most influential people in global health.

There may be a link between chronic kidney disease and the onset of migraines in Korean adults, according to data from a nationwide longitudinal follow-up study.

The FDA has approved an updated label for Lupkynis, an oral treatment for active lupus nephritis, that includes long-term safety and tolerability data, and eases the requirement for monthly kidney function assessments.